Stocks · News reference
Clover Health Stock Pops: What's Happening?
Clover Health Investments shares are jumping after CMS awarded the company's Medicare Advantage plans high 2027 Star ratings.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
UBS Adjusts Price Target on Clover Health Investments to $5.50
UBS has raised its price target for Clover Health Investments, Corp. from $5.00 to $5.50 while maintaining a Neutral rating.
Clover Health Reports Third Quarter 2026 Financial Results
Clover Health Investments, Corp. announced its financial results for the third quarter of 2026, reporting revenue of $759.3 million.
Clover Health Investments Q3 EPS $0.01 Beats $(0.00) Estimate, Sales $759.304M Beat $738.423M Estimate
This Rubrik Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Thursday
Analysts initiated bullish coverage on Rubrik, Kardigan, MSG Rangers and Ormat Technologies, with price targets of $155, $50, $257 and $123.
Needham Initiates Coverage of Clover Health Investments with Buy Rating
Needham & Company has initiated research coverage on Clover Health Investments, Corp. with a 'Buy' rating and a price target of $6.00.